United States Vaccines Market is Expected to Grow at a CAGR of 5.91% by 2032

Base Year: 2023

Historical Years: 2018-2023

Forecast Years: 2024-2032

Market Growth Rate (2024-2032): 5.91%

According to the latest report by IMARC Group, the Unites States vaccines market size is projected to exhibit a growth rate (CAGR) of 5.91% during 2024-2032. The market in United States is majorly driven by the increasing incidence of infectious diseases, including seasonal flu, hepatitis, and pneumonia, continues to fuel the demand for vaccines as preventive measures. 

The rapid advancement of biotechnology and genetic engineering has enabled the development of more targeted and effective vaccines, particularly for diseases that were previously difficult to treat. Moreover, the expansion of travel and globalization has increased the risk of cross-border disease transmission, raising the need for vaccines to prevent the spread of diseases like Zika, malaria, and tuberculosis. The growing trend of personalized healthcare, which includes personalized vaccines based on individual genetic profiles, is opening new frontiers in the vaccines market. Increased funding and investment in vaccine research and development, particularly from public-private partnerships, have accelerated the introduction of new vaccines for diseases that lack effective treatments. The increasing number of vaccine distribution networks and partnerships with local healthcare providers is improving access to vaccines, especially in underserved areas.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/united-states-vaccines-market/requestsample

The scope of the market in the United States is expanding as innovations in vaccine development continue to meet new healthcare challenges. As per the market analysis, there are substantial growth opportunities in the creation of vaccines targeting autoimmune diseases, which are seeing increasing prevalence in the population. The broadening market scope is further driven by the growth in adult vaccination programs, where increasing awareness of vaccines' importance in maintaining long-term health is encouraging broader vaccine adoption. The market is also witnessing growth in the area of combination vaccines, which reduce the number of shots required for immunity, enhancing patient compliance. With the rise in chronic disease management and the demand for vaccines to prevent diseases like cancer and Alzheimer’s, the market is diversifying to meet these needs. Additionally, there is an emerging demand for vaccines that provide protection against vector-borne diseases due to climate change and shifting disease patterns. As healthcare providers and pharmaceutical companies focus on increasing vaccine availability and affordability, the expanding role of telemedicine and digital platforms for vaccine awareness and administration further creates new growth opportunities in the market.

The report has segmented the market into the following categories:

Technology Insights:

• Conjugate Vaccines
• Inactivated and Subunit Vaccines
• Live Attenuated Vaccines
• Recombinant Vaccines
• Toxoid Vaccines
• Others

Patient Type Insights:

• Pediatric
• Adult

Indication Insights:

• Bacterial Diseases
  • Meningococcal Disease
  • Pneumococcal Disease
  • Diphtheria/Tetanus/Pertussis (DPT)
  • Tuberculosis
  • Haemophilus Influenzae (Hib)
  • Typhoid
  • Others
• Viral Diseases
  • Hepatitis
  • Influenza
  • Human Papillomavirus (HPV)
  • Measles/Mumps/Rubella (MMR)
  • Rotavirus
  • Herpes Zoster
  • Varicella
  • Japanese Encephalitis
  • Rubella
  • Polio
  • Rabies
  • Dengue
  • Others

Route of Administration Insights:

• Intramuscular and Subcutaneous Administration
• Oral Administration
• Others

Product Type Insights:

• Multivalent Vaccine
• Monovalent Vaccine

Treatment Type Insights:

• Preventive Vaccine
• Therapeutic Vaccine

End User Insights:

• Hospitals
• Clinics
• Vaccination Centers
• Academic and Research Institutes
• Others

Distribution Channel Insights:

• Hospital Pharmacies
• Retail Pharmacies
• Institutional Sales
• Others

Regional Insights:

• Northeast
• Midwest
• South
• West

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Ask Our Expert & Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=19991&flag=C

Key highlights of the Report:

• Market Performance (2018-2023)
• Market Outlook (2024-2032)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: [email protected] 

Tel No:(D) +91 120 433 0800 

United States: +1-631-791-1145